Molecule Details
| InChIKey | SVNSNKFQLBXSEH-ISSPZXTRSA-N |
|---|---|
| Compound Name | 2-[3-[(3R,6S,9S,20R)-20-(hydrazinecarbonyl)-3-(1H-indol-3-ylmethyl)-9-(naphthalen-2-ylmethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,15-pentazacycloicos-6-yl]propyl]guanidine |
| Canonical SMILES | NNC(=O)[C@H]1CCCCNC(=O)CCC(=O)N[C@@H](Cc2ccc3ccccc3c2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.46 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile